Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent

Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent

10.1002/chem.201200482

Saved in:
Bibliographic Details
Main Authors: Yang, P.-Y., Wang, M., Liu, K., Ngai, M.H., Sheriff, O., Lear, M.J., Sze, S.K., He, C.Y., Yao, S.Q.
Other Authors: CHEMISTRY
Format: Article
Published: 2014
Subjects:
antiparasite agents
drug discovery
orlistat
proteomics
trypanosomiasis
Online Access:http://scholarbank.nus.edu.sg/handle/10635/76725
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-76725
record_format dspace
spelling sg-nus-scholar.10635-767252023-10-26T09:30:32Z Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent Yang, P.-Y. Wang, M. Liu, K. Ngai, M.H. Sheriff, O. Lear, M.J. Sze, S.K. He, C.Y. Yao, S.Q. CHEMISTRY BIOLOGICAL SCIENCES antiparasite agents drug discovery orlistat proteomics trypanosomiasis 10.1002/chem.201200482 Chemistry - A European Journal 18 27 8403-8413 CEUJE 2014-06-23T05:46:19Z 2014-06-23T05:46:19Z 2012-07-02 Article Yang, P.-Y., Wang, M., Liu, K., Ngai, M.H., Sheriff, O., Lear, M.J., Sze, S.K., He, C.Y., Yao, S.Q. (2012-07-02). Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent. Chemistry - A European Journal 18 (27) : 8403-8413. ScholarBank@NUS Repository. https://doi.org/10.1002/chem.201200482 09476539 http://scholarbank.nus.edu.sg/handle/10635/76725 000305560200020 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic antiparasite agents
drug discovery
orlistat
proteomics
trypanosomiasis
spellingShingle antiparasite agents
drug discovery
orlistat
proteomics
trypanosomiasis
Yang, P.-Y.
Wang, M.
Liu, K.
Ngai, M.H.
Sheriff, O.
Lear, M.J.
Sze, S.K.
He, C.Y.
Yao, S.Q.
Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent
description 10.1002/chem.201200482
author2 CHEMISTRY
author_facet CHEMISTRY
Yang, P.-Y.
Wang, M.
Liu, K.
Ngai, M.H.
Sheriff, O.
Lear, M.J.
Sze, S.K.
He, C.Y.
Yao, S.Q.
format Article
author Yang, P.-Y.
Wang, M.
Liu, K.
Ngai, M.H.
Sheriff, O.
Lear, M.J.
Sze, S.K.
He, C.Y.
Yao, S.Q.
author_sort Yang, P.-Y.
title Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent
title_short Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent
title_full Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent
title_fullStr Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent
title_full_unstemmed Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent
title_sort parasite-based screening and proteome profiling reveal orlistat, an fda-approved drug, as a potential anti trypanosoma brucei agent
publishDate 2014
url http://scholarbank.nus.edu.sg/handle/10635/76725
_version_ 1781783650179743744

Similar Items